Aadi Bioscience (AADI)
NASDAQ:AADI

Aadi Bioscience (AADI) Financial Statements

371 Followers

Aadi Bioscience Financial Overview

Aadi Bioscience's market cap is currently ―. The company's EPS TTM is $-2.636; its P/E ratio is -2.94; Aadi Bioscience is scheduled to report earnings on August 9, 2023, and the estimated EPS forecast is $-0.62. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 5.87M$ 5.23M$ 4.25M$ 3.44M$ 2.31M
Gross Profit$ 5.34M$ 5.00M$ 3.65M$ 3.10M$ 2.13M
EBIT$ -16.82M$ -15.47M$ -14.42M$ -18.20M$ -13.80M
EBITDA$ -17.99M$ -16.49M$ -14.40M$ -18.18M$ -13.72M
Net Income Common Stockholders$ -15.22M$ -13.91M$ -14.47M$ -18.27M$ -13.86M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 151.17M$ 172.56M$ 183.01M$ 118.74M$ 129.85M
Total Assets$ 170.65M$ 184.24M$ 194.10M$ 128.64M$ 142.32M
Total Debt$ 1.57M$ 1.66M$ 1.72M$ 1.77M$ 587.00K
Net Debt$ -149.61M$ -170.90M$ -181.29M$ -116.97M$ -129.26M
Total Liabilities$ 24.67M$ 25.86M$ 25.00M$ 19.91M$ 17.69M
Stockholders Equity$ 145.99M$ 158.38M$ 169.11M$ 108.73M$ 124.63M
Cash Flow-
Free Cash Flow$ -22.66M$ -11.39M$ -8.30M$ -10.96M$ -19.44M
Operating Cash Flow$ -21.29M$ -11.31M$ -8.20M$ -10.72M$ -19.41M
Investing Cash Flow$ 16.33M$ -84.38M$ -48.24M$ -241.00K$ -23.00K
Financing Cash Flow$ 8.00K$ -107.00K$ 72.52M$ -87.00K$ 298.00K
Currency in USD

Aadi Bioscience Earnings and Revenue History


Aadi Bioscience Debt to Assets


Aadi Bioscience Cash Flow


Aadi Bioscience Forecast EPS vs Actual EPS


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis